Tenaya Therapeutics, Inc. Current Liabilities
Tenaya Therapeutics, Inc. (TNYA) had Current Liabilities of $19.02 million as of 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:LiabilitiesCurrent · last filed 2026-08-05
- 2026-06-30: Liabilities, Current $19.02M.
- 2026-03-31: Liabilities, Current $16.78M.
- 2025-12-31: Liabilities, Current $15.44M.
- 2025-09-30: Liabilities, Current $13.21M.
| Period end | Liabilities, Current |
|---|---|
| 2026-06-30 | $19.02M 10-Q · filed 2026-08-05 |
| 2026-03-31 | $16.78M 10-Q · filed 2026-05-06 |
| 2025-12-31 | $15.44M 10-Q · filed 2026-08-05 |
| 2025-09-30 | $13.21M 10-Q · filed 2025-11-10 |
| 2025-06-30 | $12.65M 10-Q · filed 2025-08-06 |
| 2025-03-31 | $14.15M 10-Q · filed 2025-05-07 |
| 2024-12-31 | $15.97M 10-K · filed 2026-03-11 |
| 2024-09-30 | $16.18M 10-Q · filed 2024-11-06 |
| 2024-06-30 | $16.71M 10-Q · filed 2024-08-08 |
| 2024-03-31 | $19.16M 10-Q · filed 2024-05-14 |
| 2023-12-31 | $22.73M 10-K · filed 2025-03-10 |
| 2023-09-30 | $19.38M 10-Q · filed 2023-11-08 |
| 2023-06-30 | $20.92M 10-Q · filed 2023-08-09 |
| 2023-03-31 | $19.30M 10-Q · filed 2023-05-10 |
| 2022-12-31 | $24.25M 10-K · filed 2024-03-18 |
| 2022-09-30 | $17.72M 10-Q · filed 2022-11-10 |
| 2022-06-30 | $18.74M 10-Q · filed 2022-08-10 |
| 2022-03-31 | $19.09M 10-Q · filed 2022-05-11 |
| 2021-12-31 | $21.77M 10-K · filed 2023-03-08 |
| 2021-09-30 | $13.69M 10-Q · filed 2021-11-10 |
| 2021-06-30 | $9.80M 10-Q · filed 2021-09-08 |
| 2020-12-31 | $5.04M 10-K · filed 2022-03-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Caribou Biosciences, Inc. (CRBU) | United States | $0.134B | -1.79 |
| Armata Pharmaceuticals, Inc. (ARMP) | United States | $0.132B | |
| Neumora Therapeutics, Inc. (NMRA) | United States | $0.132B | -1.48 |
| enGene Therapeutics Inc. (ENGN) | $0.129B | -0.92 | |
| Humacyte, Inc. (HUMA) | United States | $0.155B | -2.26 |
| Outlook Therapeutics, Inc. (OTLK) | United States | $0.162B | -4.90 |
| Acumen Pharmaceuticals, Inc. (ABOS) | United States | $0.162B | -1.83 |
| LENZ Therapeutics, Inc. (LENZ) | United States | $0.117B | -1.41 |
| Black Diamond Therapeutics, Inc. (BDTX) | United States | $0.109B | -2.48 |
| Voyager Therapeutics, Inc. (VYGR) | United States | $0.173B | -1.99 |